Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Occult Hepatitis B Virus (Hbv) Infection: A Global Challenge for Medicine Publisher Pubmed



Assar S1 ; Arababadi MK1 ; Ahmadabadi BN1 ; Salehi M2 ; Kennedy D3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Immunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  2. 2. Department of Genetics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. School of Biomolecular and Physical Science, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, QLD, Australia

Source: Clinical Laboratory Published:2012


Abstract

Hepatitis B virus (HBV) is a serious risk as a disease that can be spread through blood transfusion. Occult hepatitis B infection (OBI) is defined in a patient with the presence of HBV-DNA but a lack of HBsAg in the serum and hepatocytes. OBI can be considered as a high potential risk factor for inducing post transfusion hepatitis (PTH), hepatocellular carcinoma (HCC), cirrhosis, and reactivation of the HBV. Recently, several investigations from various regions of the world have reported PTH as well as HCC and cirrhosis among blood recipients with diseases such as thalassemia and other disorders requiring regular hemodialysis. This form of hepatitis also causes complications for individuals that are co-infected with other viruses such as HCV and HIV. Because of its extreme disease potential, OBI can be considered a high risk for PTH, HCC, and cirrhosis. Therefore, an understanding of the prevalence of OBI among blood donors is a critical strategy in most transfusion services. This review addresses the recent information regarding the prevalence of OBI worldwide, with an additional focus on Iranian blood donors.
Other Related Docs
9. Hepatitis G Virus Exposure in Dialysis Patients and Blood Donors in Isfahan-Iran, International Journal of Preventive Medicine (2014)
12. Prevalence of Anti Hcv Infection in Patients With Beta-Thalassemia in Isfahan-Iran, International Journal of Preventive Medicine (2012)
26. Occult Hepatitis B Among Iranian Hepatitis C Patients, Journal of Research in Medical Sciences (2009)
30. Seroprevalence of Hepatitis B in Nahavand, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2006)
35. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)
45. Hepatic Steatosis in Iranian Patients With Chronic Hepatitis C, Medical Principles and Practice (2008)
46. Hepatitis E Virus in Isfahan Province: A Population-Based Study, International Journal of Infectious Diseases (2009)
47. Hav in Isfahan Province: A Population-Based Study., Tropical gastroenterology : official journal of the Digestive Diseases Foundation (2008)
48. Liver Steatosis in Patients With Chronic Hepatitis B Infection: Host and Viral Risk Factors, European Journal of Gastroenterology and Hepatology (2009)
49. Prevention of Hepatitis B Virus Reactivation in Kidney Transplant Recipients, Journal of Babol University of Medical Sciences (2016)